News Safety restrictions spell the end for Servier osteoporosis d... Sales of Protelos hit by safety restrictions.
News ESMO26: 'Unprecedented' results from DeLLphi-305 in SCLC Amgen has revealed data that it hopes will move its DLL3-targeting T cell engager Imdelltra into the first-line setting in small cell lung cancer.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.